p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells

被引:69
作者
Zhang, SL [1 ]
Broxmeyer, HE
机构
[1] Indiana Univ, Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[4] Walther Canc Inst, Indianapolis, IN 46206 USA
关键词
D O I
10.1006/bbrc.1998.9959
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Flt3/Flk2 belongs to class III receptor tyrosine kinases. Like other members of type III receptor tyrosine kinases, murine Flt3 induces tyrosine phosphorylation of p85 and subsequently activation of PI3 kinase upon FL binding. While p85 binds murine Flt3 at Y958 in the carboxyl terminus of the receptor, human Flt3 does not have a potential p85-binding site in the carboxyl terminus. In this study, we examined whether p85 binds to human Flt3 in Baf3/Flt3 and THP-1 cells. In contrast to murine Flt3, p85 is not tyrosine phosphorylated after FL stimulation, nor does it bind Flt3 in both cell lines. Instead p85 associates inducibly with tyrosine phosphorylated SHP-2 and constitutively with SHIP and two tyrosine phosphorylated proteins with molecular weights about 100-kDa (p100) and 120-kDa (p120) in Baf3/Flt3 cells. The p100 associates with both p85 and SHP-2. In THP-1 cells, p85 associates inducibly with tyrosine phosphorylated SHIP, p100 and p120. These results indicate that p85 does not bind human Flt3, but forms a complex with SHP-2, SHIP, p100 and p120 in hematopoietic cells. (C) 1999 Academic Press.
引用
收藏
页码:440 / 445
页数:6
相关论文
共 34 条
  • [21] LYMAN SD, 1993, ONCOGENE, V8, P815
  • [22] LYMAN SD, 1995, INT J HEMATOL, V62, P63
  • [23] MOLECULAR-CLONING OF A LIGAND FOR THE FLT3/FLK-2 TYROSINE KINASE RECEPTOR - A PROLIFERATIVE FACTOR FOR PRIMITIVE HEMATOPOIETIC-CELLS
    LYMAN, SD
    JAMES, L
    VANDENBOS, T
    DEVRIES, P
    BRASEL, K
    GLINIAK, B
    HOLLINGSWORTH, LT
    PICHA, KS
    MCKENNA, HJ
    SPLETT, RR
    FLETCHER, FA
    MARASKOVSKY, E
    FARRAH, T
    FOXWORTHE, D
    WILLIAMS, DE
    BECKMANN, MP
    [J]. CELL, 1993, 75 (06) : 1157 - 1167
  • [24] CLONING OF THE HUMAN HOMOLOG OF THE MURINE FLT3 LIGAND - A GROWTH-FACTOR FOR EARLY HEMATOPOIETIC PROGENITOR CELLS
    LYMAN, SD
    JAMES, L
    JOHNSON, L
    BRASEL, K
    DEVRIES, P
    ESCOBAR, SS
    DOWNEY, H
    SPLETT, RR
    BECKMANN, MP
    MCKENNA, HJ
    [J]. BLOOD, 1994, 83 (10) : 2795 - 2801
  • [25] c-kit ligand and flt3 ligand:: Stem/progenitor cell factors with overlapping yet distinct activities
    Lyman, SD
    Jacobsen, SEW
    [J]. BLOOD, 1998, 91 (04) : 1101 - 1134
  • [26] LYMAN SD, 1994, STEM CELLS, V12, P99
  • [27] TARGETED DISRUPTION OF THE FLK2/FLT3 GENE LEADS TO DEFICIENCIES IN PRIMITIVE HEMATOPOIETIC PROGENITORS
    MACKAREHTSCHIAN, K
    HARDIN, JD
    MOORE, KA
    BOAST, S
    GOFF, SP
    LEMISCHKA, IR
    [J]. IMMUNITY, 1995, 3 (01) : 147 - 161
  • [28] MAROC N, 1993, ONCOGENE, V8, P909
  • [29] EFFECT OF FLT3 LIGAND ON THE EX-VIVO EXPANSION OF HUMAN CD34(+) HEMATOPOIETIC PROGENITOR CELLS
    MCKENNA, HJ
    DEVRIES, P
    BRASEL, K
    LYMAN, SD
    WILLIAMS, DE
    [J]. BLOOD, 1995, 86 (09) : 3413 - 3420
  • [30] ROSNET O, 1993, CRIT REV ONCOGENESIS, V4, P595